We are live on ! Find out more
IMGN

Immunogen Inc

Delisted

IMGN was delisted on the 9th of February, 2024.

204 hedge funds and large institutions have $1.1B invested in Immunogen Inc in 2018 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 59 increasing their positions, 69 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

66% more capital invested

Capital invested by funds: $666M → $1.1B (+$438M)

19% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 37

2% more funds holding

Funds holding: 200204 (+4)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

14% less repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 69

68% less call options, than puts

Call options by funds: $8.85M | Put options by funds: $27.5M

Holders
204
Holders Change
+4
Holders Change %
+2%
% of All Funds
4.68%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
44
Increased
59
Reduced
69
Closed
37
Calls
$8.85M
Puts
$27.5M
Net Calls
-$18.6M
Net Calls Change
-$20.2M
Name Holding Trade Value Shares
Change
Change in
Stake
Stifel Financial
76
Stifel Financial
Missouri
$839K -$523K -52,931 -38%
Janney Montgomery Scott
77
Janney Montgomery Scott
Pennsylvania
$839K +$50.3K +5,089 +7%
State Board of Administration of Florida Retirement System
78
State Board of Administration of Florida Retirement System
Florida
$813K -$37.1K -3,753 -5%
BTS
79
BB&T Securities
Virginia
$806K -$107K -10,870 -12%
Manulife (Manufacturers Life Insurance)
80
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$789K -$21.6K -2,183 -3%
ProShare Advisors
81
ProShare Advisors
Maryland
$778K -$120K -12,162 -14%
Lazard Asset Management
82
Lazard Asset Management
New York
$776K +$156K +15,772 +27%
Balyasny Asset Management
83
Balyasny Asset Management
Illinois
$716K +$425K +43,045 +172%
DZ Bank
84
DZ Bank
Germany
$695K +$652K +66,040 New
VF
85
Virtu Financial
New York
$687K +$645K +65,301 New
AIG
86
American International Group
New York
$672K -$33.9K -3,432 -5%
N
87
Nuveen
North Carolina
$652K
DekaBank Deutsche Girozentrale
88
DekaBank Deutsche Girozentrale
Germany
$608K +$559K +56,600 New
BBI
89
Baxter Bros Inc
Connecticut
$587K -$21.7K -2,200 -4%
TD Asset Management
90
TD Asset Management
Ontario, Canada
$585K +$68.2K +6,900 +14%
MIM
91
MetLife Investment Management
New Jersey
$484K
VOYA Investment Management
92
VOYA Investment Management
Georgia
$461K
Squarepoint
93
Squarepoint
New York
$433K +$407K +41,200 New
LPL Financial
94
LPL Financial
California
$400K -$78.7K -7,967 -17%
RJFSA
95
Raymond James Financial Services Advisors
Florida
$379K +$237K +23,982 +198%
NFC
96
Northeast Financial Consultants
Connecticut
$360K
MLICM
97
Metropolitan Life Insurance Company (MetLife)
New York
$354K +$35.1K +3,552 +12%
AIM
98
Assured Investment Management
New York
$351K +$329K +33,318 New
NIT
99
NumerixS Investment Technologies
British Columbia, Canada
$343K -$85.5K -8,661 -21%
SAM
100
Silphium Asset Management
United Kingdom
$342K +$321K +32,547 New

IMGN Hedge Fund Activity: Q1 2018 in Review

204 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q1 2018, worth a combined $1.1B — up 66% from $666M a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new IMGN positions and 37 closed out — a net gain of 7 holders — while 59 added to existing stakes and 69 trimmed.

The largest buyer was Capital Research Global Investors, opening a new position worth an estimated $54.4M. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $16.4M sold.

  • 204 institutional investors held Immunogen Inc (IMGN) as of Q1 2018, up from 200 in Q4 2017.
  • Funds reported $1.1B of Immunogen Inc stock for Q1 2018, up 66% quarter-over-quarter.
  • 44 funds opened new Immunogen Inc positions in Q1 2018 and 37 closed out, a net change of +7 holders.
  • The largest Immunogen Inc buyer in Q1 2018 was Capital Research Global Investors, an estimated $54.4M added.
  • The largest Immunogen Inc seller in Q1 2018 was Baker Bros. Advisors, an estimated $16.4M sold.

Based on aggregated 13F filings for Q1 2018.